Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Primary ciliogenesis is promoted during epithelial-mesenchymal transition via a miR-200 - DZIP1 axis.

Cell communication and signaling : CCS·2026

Same author

Strongly regulated transcription factors exert an outsized influence in microRNA-regulated networks.

Cell communication and signaling : CCS·2025

Same author

Chasing non-existent "microRNAs" in cancer.

Oncogenesis·2025

Same author

TRanscriptome ANalysis of StratifiEd CohorTs (TRANSECT) enables automated assessment of global gene regulation linked to disparate expression in user defined genes and gene sets.

NAR genomics and bioinformatics·2025

Same author

A Dual-Selection System for Enhanced Efficiency and Fidelity of Circular RNA Overexpression.

Journal of molecular biology·2025

Same author

Erratum to "RNA regulatory mechanisms controlling TGF-β signaling and EMT in cancer" [Semin. Cancer Biol. 102-103 (2024) 4-16].

Seminars in cancer biology·2024

Search research articles

Related Experiment Video

Updated: Jun 16, 2026

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

Myc-modulated miR-9 makes more metastases.

Yeesim Khew-Goodall¹, Gregory J Goodall

¹Centre for Cancer Biology, SA Pathology, Adelaide, Australia.

Nature Cell Biology

|February 23, 2010

Summary

The microRNA miR-9, induced by Myc in breast cancer, targets E-cadherin. This promotes cancer cell invasion via epithelial-mesenchymal transition (EMT) and stimulates tumor angiogenesis.

Area of Science:

Molecular Biology
Cancer Research
Cell Biology

Background:

MicroRNAs (miRNAs) play crucial roles in cancer development and progression.
The transcription factor Myc is frequently overexpressed in various cancers, including breast cancer.
Epithelial-mesenchymal transition (EMT) is a key process in cancer metastasis and angiogenesis is critical for tumor growth.

Purpose of the Study:

To investigate the role of microRNA miR-9 in Myc-driven breast cancer.
To identify the targets of miR-9 in breast cancer cells.
To understand how miR-9 influences epithelial-mesenchymal transition (EMT) and angiogenesis.

Main Methods:

Analysis of miR-9 expression in breast cancer cells.
Luciferase reporter assays to confirm E-cadherin as a miR-9 target.

More Related Videos

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Published on: December 19, 2019

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

Related Experiment Videos

Last Updated: Jun 16, 2026

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Published on: December 19, 2019

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

In vitro assays to assess EMT markers and angiogenesis-related factors.

Main Results:

Myc induces the expression of miR-9 in breast cancer cells.
miR-9 directly targets and downregulates the expression of E-cadherin.
Downregulation of E-cadherin by miR-9 promotes EMT and stimulates angiogenesis.

Conclusions:

miR-9 is a key mediator of Myc's oncogenic functions in breast cancer.
Targeting miR-9 may represent a novel therapeutic strategy for breast cancer.
The miR-9/E-cadherin axis contributes to tumor progression by promoting EMT and angiogenesis.